title: Toxicity of zinc oxide nanoparticles in rats treated by two different routes: single intravenous injection and single oral administration.
abstract: Toxicokinetics of zinc oxide nanoparticles (ZnONP) was studied in rats via a single intravenous (iv) injection and a single oral administration (3 mg/kg or 30 mg/kg), respectively. Blood concentrations of zinc (Zn) were monitored for 7 d and tissue distribution were determined in liver, kidneys, lung, spleen, thymus, brain, and testes. To ascertain the excretion of ZnONP, Zn levels in urine and feces were measured for 7 d. ZnONP were not readily absorbed from the gastrointestinal tract (GIT) after oral administration and were excreted mostly in feces. When the nanoparticles were injected iv to rats at a dose of 30 mg/kg, peak concentration appeared at 5 min but returned to normal range by d 2 (48 h after injection). ZnONP were distributed mainly to liver, kidneys, lung, and spleen, but not to thymus, brain, and testes. The distribution level was significantly decreased to normal by d 7. Feces excretion levels after iv injection supported biliary excretion of ZnONP. In rats injected iv with 30 mg/kg, mitotic figures in hepatocytes were significantly increased and multifocal acute injuries with dark brown pigment were noted in lungs, while no significant damage was observed in rats treated orally with the same dosage.
authors: a College of Pharmacy , Dongduk Women's University , Seoul , Korea.
authors: Jonghye
authors: J
authors: Choi
authors: Heyjin
authors: H
authors: Kim
authors: Pilje
authors: P
authors: Kim
authors: Eunhye
authors: E
authors: Jo
authors: Hyun-Mi
authors: HM
authors: Kim
authors: Moo-Yeol
authors: MY
authors: Lee
authors: Seon Mi
authors: SM
authors: Jin
authors: Kwangsik
authors: K
authors: Park
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005243:Feces / Q000737:chemistry; D041981:Gastrointestinal Tract / Q000187:drug effects / Q000378:metabolism; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects / Q000378:metabolism; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000378:metabolism; D008297:Male; D053758:Nanoparticles / Q000737:chemistry / Q000633:toxicity*; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D013154:Spleen / Q000187:drug effects / Q000378:metabolism; D013737:Testis / Q000187:drug effects / Q000378:metabolism; D013950:Thymus Gland / Q000187:drug effects / Q000378:metabolism; D014018:Tissue Distribution; D015032:Zinc / Q000493:pharmacokinetics; D015034:Zinc Oxide / Q000493:pharmacokinetics / Q000633:toxicity*
chemical_list: D015032:Zinc; D015034:Zinc Oxide